Cargando…
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices
Paediatric multiple sclerosis (MS) represents less than 5 % of the MS population, but patients with paediatric-onset disease reach permanent disability at a younger age than adult-onset patients. Accurate diagnosis at presentation and optimal long-term treatment are vital to mitigate ongoing neuroin...
Autores principales: | Chou, I-Jun, Wang, Huei-Shyong, Whitehouse, William P., Constantinescu, Cris S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894922/ https://www.ncbi.nlm.nih.gov/pubmed/27271748 http://dx.doi.org/10.1007/s11910-016-0663-4 |
Ejemplares similares
-
Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016) -
CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017) -
Quality of Life in Multiple Sclerosis
por: Williams, Mitchell T., et al.
Publicado: (2020) -
Telehealth in Multiple Sclerosis Clinical Care and Research
por: Xiang, Xinran Maria, et al.
Publicado: (2021) -
Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
por: Schneider, Raphael, et al.
Publicado: (2022)